Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Nelarabine in Patients With Relapsed/Refractory Lymphoid Malignancies
Clinical trial NCT01094860 · COMPLETED
Trial details
- NCT number
- NCT01094860
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-06-08
- Primary completion
- 2018-08-09
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.